CSX three-lens brief
Evidence-based stock research on CSX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 8.6pp over 30 days. · Trading at 94% of its 52-week range — near the top of the band.
- Trading at 94% of its 52-week range — near the top of the band.
- RSI at 70 — technically overbought.
- Outperforming SPY by 8.6pp over 30 days.
- Debt-to-equity of 143.1 — balance-sheet-heavy.
CSX closed at $45.41 (-1.67%) as of 2026-04-25. Market cap: $84.38B. P/E (trailing) 27.9. Positives: outperforming SPY by 8.6pp over 30 days.. Concerns: trading at 94% of its 52-week range — near the top of the band.; rSI at 70 — technically overbought.. Last quarter: Revenue $3.48B, net income $807.00M, free cash flow $1.13B.
Why three lenses on CSX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CSXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CSX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CSX brief"></iframe>